Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis

• Main Authors: Rima El-Dirany (Author), Celia Fernández-Rubio (Author), José Peña-Guerrero (Author), Esther Moreno (Author), Esther Larrea (Author), Socorro Espuelas (Author), Fadi Abdel-Sater (Author), Klaus Brandenburg (Author), Guillermo Martínez- (Author), Paul Nguewa (Author)
• Format: Book
• Published: MDPI AG, 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The lack of safe and cost-effective treatments against leishmaniasis highlights the urgent need to develop improved leishmanicidal agents. Antimicrobial peptides (AMPs) are an emerging category of therapeutics exerting a wide range of biological activities such as anti-bacterial, anti-fungal, anti-p...